PortfoliosLab logoPortfoliosLab logo
RVMDW vs. BW
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RVMDW vs. BW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revolution Medicines Inc. Warrant (RVMDW) and Babcock & Wilcox Enterprises, Inc. (BW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RVMDW achieves a 688.38% return, which is significantly higher than BW's 157.29% return.


RVMDW

1D
4.07%
1M
26.88%
YTD
688.38%
6M
680.00%
1Y
3,027.90%
3Y*
5Y*
10Y*

BW

1D
-10.47%
1M
-14.33%
YTD
157.29%
6M
230.87%
1Y
1,637.54%
3Y*
37.03%
5Y*
14.97%
10Y*
-22.06%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RVMDW vs. BW - Yearly Performance Comparison


2026 (YTD)202520242023
RVMDW
Revolution Medicines Inc. Warrant
688.38%422.17%-45.45%-67.00%
BW
Babcock & Wilcox Enterprises, Inc.
157.29%286.59%12.33%-4.58%

Correlation

The correlation between RVMDW and BW is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.01

Correlation (All Time)
Calculated using the full available price history since Nov 17, 2023

0.02

Fundamentals

Market Cap

RVMDW:

$1.47B

BW:

$2.13B

EPS

RVMDW:

-$7.17

BW:

-$0.83

Total Revenue (TTM)

RVMDW:

$0.00

BW:

$668.48M

Gross Profit (TTM)

RVMDW:

-$4.70M

BW:

$121.68M

EBITDA (TTM)

RVMDW:

-$1.34B

BW:

-$41.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RVMDW vs. BW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVMDW
RVMDW Risk / Return Rank: 9999
Overall Rank
RVMDW Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
RVMDW Sortino Ratio Rank: 9999
Sortino Ratio Rank
RVMDW Omega Ratio Rank: 9898
Omega Ratio Rank
RVMDW Calmar Ratio Rank: 100100
Calmar Ratio Rank
RVMDW Martin Ratio Rank: 100100
Martin Ratio Rank

BW
BW Risk / Return Rank: 9999
Overall Rank
BW Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
BW Sortino Ratio Rank: 9898
Sortino Ratio Rank
BW Omega Ratio Rank: 9797
Omega Ratio Rank
BW Calmar Ratio Rank: 100100
Calmar Ratio Rank
BW Martin Ratio Rank: 100100
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVMDW vs. BW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Revolution Medicines Inc. Warrant (RVMDW) and Babcock & Wilcox Enterprises, Inc. (BW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RVMDWBWDifference
Sharpe ratioReturn per unit of total volatility

-0.12

Sortino ratioReturn per unit of downside risk

+0.50

Omega ratioGain probability vs. loss probability

1.76

1.68

+0.08

Calmar ratioReturn relative to maximum drawdown

51.49

49.16

+2.33

Martin ratioReturn relative to average drawdown

112.99

129.58

-16.59

RVMDW vs. BW - Sharpe Ratio Comparison

The current RVMDW Sharpe Ratio is 12.97, which is comparable to the BW Sharpe Ratio of 13.09. The chart below compares the historical Sharpe Ratios of RVMDW and BW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RVMDW vs. BW - Drawdown Comparison

The maximum RVMDW drawdown since its inception was -96.90%, roughly equal to the maximum BW drawdown of -99.89%. Use the drawdown chart below to compare losses from any high point for RVMDW and BW.


Loading charts...

Drawdown Indicators


RVMDWBWDifference

Max Drawdown

Largest peak-to-trough decline

-96.90%

-99.89%

+2.99%

Max Drawdown (1Y)

Largest decline over 1 year

-59.65%

-33.71%

-25.94%

Max Drawdown (3Y)

Largest decline over 3 years

-95.93%

Max Drawdown (5Y)

Largest decline over 5 years

-97.39%

Max Drawdown (10Y)

Largest decline over 10 years

-99.87%

Current Drawdown

Current decline from peak

0.00%

-93.11%

+93.11%

Average Drawdown

Average peak-to-trough decline

-66.06%

-82.82%

+16.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.13%

12.77%

+14.36%

Volatility

RVMDW vs. BW - Volatility Comparison

Revolution Medicines Inc. Warrant (RVMDW) has a higher volatility of 33.80% compared to Babcock & Wilcox Enterprises, Inc. (BW) at 25.81%. This indicates that RVMDW's price experiences larger fluctuations and is considered to be riskier than BW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RVMDWBWDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.80%

25.81%

+7.99%

Volatility (6M)

Calculated over the trailing 6-month period

149.62%

88.27%

+61.35%

Volatility (1Y)

Calculated over the trailing 1-year period

237.26%

126.74%

+110.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

311.22%

110.34%

+200.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

311.22%

108.35%

+202.87%

Dividends

RVMDW vs. BW - Dividend Comparison

RVMDW has not paid dividends to shareholders, while BW's dividend yield for the trailing twelve months is around 2.55%.


Financials

RVMDW vs. BW - Financials Comparison

This section allows you to compare key financial metrics between Revolution Medicines Inc. Warrant and Babcock & Wilcox Enterprises, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M202220232024202520260
214.41M
(RVMDW) Total Revenue
(BW) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RVMDW and BW have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RVMDW has higher volatility (33.80%) compared to BW (25.81%). In terms of maximum drawdown, RVMDW dropped -96.90% vs BW's -99.89%.

BW currently has the higher Sharpe Ratio (13.09 vs 12.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RVMDW and BW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer